Are We Getting Closer to the "Cholesterol" for Chronic Respiratory Disease?
作者信息
Mannino David M, Wright Jean
机构信息
COPD Foundation, Miami, Florida, United States.
University of Kentucky College of Medicine, Department of Medicine, Lexington, Kentucky, United States;
出版信息
Am J Respir Crit Care Med. 2024 Sep 12;211(1):6-7. doi: 10.1164/rccm.202407-1480ED.
Abstract
摘要
相似文献
1
Are We Getting Closer to the "Cholesterol" for Chronic Respiratory Disease?我们离慢性呼吸道疾病的“胆固醇”（指标）更近了吗？
Am J Respir Crit Care Med. 2024 Sep 12;211(1):6-7. doi: 10.1164/rccm.202407-1480ED.
2
Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?慢性阻塞性肺疾病患者评估和管理中的系统生物标志物：我们是否更接近临床应用？
Curr Drug Targets. 2013 Feb;14(2):177-91. doi: 10.2174/1389450111314020005.
3
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.PCSK9 基因变异与中、英人群血管和非血管疾病风险的关系。
Eur J Prev Cardiol. 2024 Jun 3;31(8):1015-1025. doi: 10.1093/eurjpc/zwae009.
4
Association Between the Non-High-Density Lipoprotein Cholesterol-to-High-Density Lipoprotein Cholesterol Ratio (NHHR) and Mortality in Patients with COPD: Evidence From the NHANES 1999-2018.慢性阻塞性肺疾病（COPD）患者非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值（NHHR）与死亡率之间的关联：来自1999 - 2018年美国国家健康与营养检查调查（NHANES）的证据
Int J Chron Obstruct Pulmon Dis. 2025 Mar 28;20:857-868. doi: 10.2147/COPD.S508481. eCollection 2025.
5
The association between total cholesterol and cognitive impairment in chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者总胆固醇与认知障碍之间的关联。
Prostaglandins Other Lipid Mediat. 2023 Feb;164:106697. doi: 10.1016/j.prostaglandins.2022.106697. Epub 2022 Nov 5.
6
Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study.急性呼吸窘迫综合征患者中慢性阻塞性肺疾病或肺气肿患病率的临床和生物学特征；一项队列研究。
Respir Res. 2024 Nov 8;25(1):400. doi: 10.1186/s12931-024-03027-2.
7
Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者血清中脂质生物标志物的鉴定。
Respir Res. 2020 Sep 21;21(1):242. doi: 10.1186/s12931-020-01507-9.
8
Blood biomarkers associated with acute type II respiratory failure in COPD: A meta-analysis.与 COPD 急性 II 型呼吸衰竭相关的血液生物标志物：一项荟萃分析。
Clin Respir J. 2022 Feb;16(2):75-83. doi: 10.1111/crj.13464. Epub 2022 Jan 10.
9
Associations of Platelet to High-Density Lipoprotein Cholesterol Ratio with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study from the US National Health and Nutrition Examination Survey.血小板与高密度脂蛋白胆固醇比值与慢性阻塞性肺疾病的相关性：来自美国国家健康和营养检查调查的横断面研究。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 23;19:2321-2332. doi: 10.2147/COPD.S481197. eCollection 2024.
10
Differential responses of healthy and chronic obstructive pulmonary diseased human bronchial epithelial cells repeatedly exposed to air pollution-derived PM.健康和慢性阻塞性肺疾病患者的人支气管上皮细胞反复暴露于空气污染衍生的细颗粒物后的差异反应。
Environ Pollut. 2016 Nov;218:1074-1088. doi: 10.1016/j.envpol.2016.08.059. Epub 2016 Sep 1.
本文引用的文献
1
Proteomic Risk Score of Increased Respiratory Susceptibility: A Multi-Cohort Study.呼吸道易感性增加的蛋白质组学风险评分：一项多队列研究
Am J Respir Crit Care Med. 2024 Sep 10;211(1):64-74. doi: 10.1164/rccm.202403-0613OC.
2
Demographic and geographical trends in chronic lower respiratory diseases mortality in the United States, 1999 to 2020.美国 1999 年至 2020 年慢性下呼吸道疾病死亡率的人口统计学和地理趋势。
Respir Res. 2024 Jun 24;25(1):258. doi: 10.1186/s12931-024-02880-5.
3
Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.快速分子诊断检测对出现病毒性呼吸道症状患者的临床影响：一项系统文献综述
PLoS One. 2024 Jun 13;19(6):e0303560. doi: 10.1371/journal.pone.0303560. eCollection 2024.
4
The COPD Foundation on Its Twentieth Anniversary.慢性阻塞性肺疾病基金会成立二十周年。
Chronic Obstr Pulm Dis. 2024 May 29;11(3):247-260. doi: 10.15326/jcopdf.2024.0527.
5
Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.COPDGene 和 CARDIA 肺研究中定量间质异常的蛋白质组学生物标志物。
Am J Respir Crit Care Med. 2024 May 1;209(9):1091-1100. doi: 10.1164/rccm.202307-1129OC.
6
Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.α1-抗胰蛋白酶缺乏症和慢性阻塞性肺疾病中肺气肿的独特和共有系统性生物标志物。
EBioMedicine. 2022 Oct;84:104262. doi: 10.1016/j.ebiom.2022.104262. Epub 2022 Sep 22.
7
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.慢性阻塞性肺疾病和慢性阻塞性肺疾病前患者的青年患者治疗试验：是时候向前推进了。
Am J Respir Crit Care Med. 2022 Feb 1;205(3):275-287. doi: 10.1164/rccm.202107-1663SO.
8
Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement.慢性阻塞性肺疾病筛查：美国预防服务工作组推荐声明。
JAMA. 2016 Apr 5;315(13):1372-7. doi: 10.1001/jama.2016.2638.
9
Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.美国未确诊的阻塞性肺病：相关因素及长期死亡率
Ann Am Thorac Soc. 2015 Dec;12(12):1788-95. doi: 10.1513/AnnalsATS.201506-388OC.
10
Trends in total and low-density lipoprotein cholesterol among U.S. adults: contributions of changes in dietary fat intake and use of cholesterol-lowering medications.美国成年人总胆固醇和低密度脂蛋白胆固醇趋势：饮食中脂肪摄入量变化和使用降胆固醇药物的贡献。
PLoS One. 2013 May 22;8(5):e65228. doi: 10.1371/journal.pone.0065228. Print 2013.
Zotero 插件